Completed PHASE1/PHASE2 INTERVENTIONAL 4-arm NCT00971230

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa

A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Kenya, Africa

Sponsor: International AIDS Vaccine Initiative

Conditions HIV Infections

Interventions FTC/TDF Placebo

Updated 6 times since 2017 Last updated: Aug 5, 2010 Started: Oct 31, 2009 Primary completion: Jun 30, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on HIV Infections, this trial is completed. The trial is conducted by International AIDS Vaccine Initiative and has accumulated 6 data snapshots since 2009. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

International AIDS Vaccine Initiative

Data source: International AIDS Vaccine Initiative

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kilifi, Kenya
• Nairobi, Kenya